Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Croma-Pharma is a leading global player in the minimally invasive aesthetic medicine market and a prominent European manufacturer of premium hyaluronic acid syringes. Founded in 1976 and headquartered in Austria, the company specializes in the development and production of innovative products for aesthetics, ophthalmology, and orthopaedics. Its core portfolio includes the saypha® range of hyaluronic acid fillers, PDO lifting threads, and the botulinum toxin Letybo, which is distributed through a strategic partnership with Hugel. Croma operates one of the world's most modern automated production lines for hyaluronic acid at its headquarters in Leobendorf. The company maintains a strong international presence, distributing its medical products to over 80 countries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Croma Aesthetics.